Literature DB >> 3871177

The effects of transcutaneous electrical nerve stimulation in patients with severe angina pectoris.

C Mannheimer, C A Carlsson, H Emanuelsson, A Vedin, F Waagstein, C Wilhelmsson.   

Abstract

The pain-relieving effects of transcutaneous electrical nerve stimulation (TENS) were investigated in patients with severe angina pectoris first with respect to systemic and coronary hemodynamics and myocardial metabolism during pacing-induced angina and second in a controlled long-term study. Two series of patients with severe angina pectoris (NYHA class III to IV) were studied (13 patients in the pacing study and 23 in the long-term study). In the pacing-induced angina study there was increased tolerance to pacing (142 +/- 23 compared with 124 +/- 20 beats/min tolerated, p less than .001), improved lactate metabolism (2 +/- 36% compared with -18 +/- 43%, p less than .01), and less pronounced ST segment depression (2.3 +/- 1.1 compared with 2.9 +/- 2.6 mm, p less than 0.05) with TENS. In the long study the effects of TENS were measured by means of repeated bicycle ergometer test, frequency of anginal attacks, and consumption of short-acting nitroglycerin. TENS was used regularly for 1 hr three times per day. The TENS treatment group had increased work capacity (637 +/- 308 vs 555 +/- 277 W . min, p greater than .001), decreased ST segment depression (2.3 +/- 1.1 vs 3.6 +/- 1.6 mm, p less than .001), reduced frequency of anginal attacks (p less than .05), and reduced consumption of short-acting nitroglycerin per week (p less than .05) compared with the control group. The observed effects were mainly due to decreased afterload resulting from systemic vascular dilatation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871177     DOI: 10.1161/01.cir.71.2.308

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

Review 1.  Neurostimulation treatment for angina pectoris.

Authors:  S Murray; P D Collins; M A James
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

Review 2.  Electrical stimulation as an adjunctive treatment of painful and sensory diabetic neuropathy.

Authors:  Gaurav Thakral; Paul J Kim; Javier LaFontaine; Robert Menzies; Bijan Najafi; Lawrence A Lavery
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

Review 3.  Electrical neurostimulators for pain relief in angina.

Authors:  J E Sanderson
Journal:  Br Heart J       Date:  1990-03

4.  Influence of naloxone on the effects of high frequency transcutaneous electrical nerve stimulation in angina pectoris induced by atrial pacing.

Authors:  C Mannheimer; H Emanuelsson; F Waagstein; C Wilhelmsson
Journal:  Br Heart J       Date:  1989-07

5.  Acute myocardial infarction following a gila monster (Heloderma suspectum cinctum) bite.

Authors:  C F Bou-Abboud; D G Kardassakis
Journal:  West J Med       Date:  1988-05

6.  Lasers, burns, cuts, tingles and pumps: a consideration of alternative treatments for intractable angina.

Authors:  D Mulcahy; C Knight; R Stables; K Fox
Journal:  Br Heart J       Date:  1994-05

7.  Esophageal visceral pain sensitivity: effects of TENS and correlation with manometric findings.

Authors:  M Börjesson; M Pilhall; T Eliasson; H Norssell; C Mannheimer; P Rolny
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

8.  Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action.

Authors:  C Mannheimer; T Eliasson; B Andersson; C H Bergh; L E Augustinsson; H Emanuelsson; F Waagstein
Journal:  BMJ       Date:  1993-08-21

Review 9.  Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

10.  The influence of transcutaneous electrical neurostimulation (TENS) on human cerebral blood flow velocities.

Authors:  Mark Ter Laan; J Marc C van Dijk; Jan-Willem J Elting; Vaclav Fidler; Michiel J Staal
Journal:  Acta Neurochir (Wien)       Date:  2010-05-15       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.